模型介绍
Pre-trained language models have attracted increasing attention in the biomedical domain, inspired by their great success in the general natural language domain. Among the two main branches of pre-trained language models in the general language domain, i.e. BERT (and its variants) and GPT (and its variants), the first one has been extensively studied in the biomedical domain, such as BioBERT and PubMedBERT. While they have achieved great success on a variety of discriminative downstream biomedical tasks, the lack of generation ability constrains their application scope. In this paper, we propose BioGPT, a domain-specific generative Transformer language model pre-trained on large-scale biomedical literature. We evaluate BioGPT on six biomedical natural language processing tasks and demonstrate that our model outperforms previous models on most tasks. Especially, we get 44.98%, 38.42% and 40.76% F1 score on BC5CDR, KD-DTI and DDI end-to-end relation extraction tasks, respectively, and 78.2% accuracy on PubMedQA, creating a new record. Our case study on text generation further demonstrates the advantage of BioGPT on biomedical literature to generate fluent descriptions for biomedical terms. You can use this model directly with a pipeline for text generation. Since the generation relies on some randomness, we set a seed for reproducibility:
主要特点
特点摘要待依据来源补齐,不凭模型名称推断能力。
局限与注意事项
暂无足够来源支持具体缺点结论。请重点验证实际任务表现、时延、数据政策、许可与版本生命周期。
来源报价与费用分析
同一模型在不同渠道、地区和配置下可能采用不同价格。下表独立保留各渠道报价,不将渠道价格视为厂商官方统一价格。
| 来源 / 渠道 | 输入 | 输出 | 计费单位 | 采集时间 |
|---|---|---|---|---|
| 暂未取得可核验报价,请查阅来源渠道。 | ||||
按月估算基础 Token 费用
预估不包含缓存优惠、阶梯定价、多模态附加费用、网络检索、税费及推理额外输出。
公开评测与运行配置
暂无已采集的可核验公开评分。模型未上榜不代表能力较低。
查看完整已收录榜单 →常见问题
开放权重是否代表可以免费商用?
不一定。应核对具体版本许可证、商用门槛和使用政策。自部署还会产生算力和维护成本。
这些价格是实时结算价格吗?
不是实时结算价格,而是带采集时间的来源报价快照。请到对应渠道核对当前版本、区域、折扣和计费方式。
资料来源与可追溯记录
许可证:mit。模型介绍与第三方评测均以原来源的具体版本和方法为准。